Neudle.com: luteinizing hormone releasing factor

Differential
(Click to cross reference)

abdominal distention

abducens nerve paralysis

acoustic nerve

acromegaly

activated protein C resistance

adverse drug reaction

altered states of consciousness

Alzheimer's disease

Alzheimer's disease, risk factors in

Alzheimer's disease, treatment of

angiography, cerebral, beaded vessels

angiography, cerebral

angiography, posterior fossa

animal exposure

antiarrhythmic drugs

antibiotics

antibiotics, neurologic complications with

anticoagulant, restarting

anticoagulant, treatment

anticoagulant, treatment in CVD

anticonvulsants

anticonvulsants, untoward effects of

antimetabolite

antioxidant

antiphospholipid antibodies

antithrombin III deficiency

apnea

area postrema

area postrema syndrome

areflexia

artane

arterial dissection

arterial dissection, carotid

arterial dissection, multiple

arterial dissection, vertebral

asparginase

aspirin

assisted reproductive technology

ataxia

ataxia, cerebellar

atherosclerosis, premature

autonomic dysfunction

benign sexual headache

beta adrenergic blocker

bevacizumab

blood dyscrasias, neurologic findings with

bovine spongiform encephalopathy

calcium antagonist, side effects of

cancer, cerebrovascular accident complicating patients with

carcinoma

cardiomyopathy

cardiovascular disease

carotid angiogram

carotid artery atherosclerosis

carotid artery disease

carotid artery stenosis

carotid artery stenosis, intracranial

CAT scan

CAT scan, abdomen

CAT scan, abnormal

CAT scan, angiography

CAT scan, cord sign

CAT scan, emission, abnormal

CAT scan, venography

central retinal artery occlusion

cerebral infarction, hemorrhagic

cerebral ischemia

cerebral veins

cerebral venous infarction

cerebral venous thrombosis

cerebral venous thrombosis, deep

cerebral venous thrombosis, etiology

cerebral venous thrombosis, recurrent

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, pressure low

cerebrospinal fluid, protein of

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, complications with

cerebrovascular accident, differential diagnosis of

cerebrovascular accident, etiology

cerebrovascular accident, non atherosclerotic cause of

cerebrovascular accident, prevention of

cerebrovascular accident, prognosis in

cerebrovascular accident, recurrent

cerebrovascular accident, secondary prevention

cerebrovascular accident, sex distribution

cerebrovascular accident, thrombolytic agents in treatment

cerebrovascular accident, women

cerebrovascular accident, young adult

cerebrovascular disease

cerebrovascular disease, predisposed factor in

cerebrovascular disease, risk factors in

cerebrovascular disease, smoking in

cervical spine injury

cervical spine manipulation

Charcot-Marie-Tooth

chemotherapy, CNS treatment and complications with

children

chiropractic manipulation

chloroquine

cholesterol

cigarette smoking

Clinical Pathologic Conference(C.P.C.)

coagulopathy

cognition

collagen vascular disease

coma

complications

confusion

congestive heart failure

constipation

controversies in neurology

corneal dystrophy

corpus callosum, infarction of

corpus callosum, lesion of

cortical vein thrombosis

corticotropin level

corticotropin-releasing factor

cortisol, elevated

coumarin

coumarin, restarting treatment

cranial neuropathy, multiple

craniectomy, decompressive

delivery, complicated

dementia

dementia, prevention of

dementia, rapidly progressive

dementia, transmissible

differential diagnosis

diplopia

drowsiness

drug induced neurologic disorders

drug interactions

dural arteriovenous malformation

dural sinus thrombosis

electroencephalogram, periodic complexes

epidemiology of neurology

erythropoietin

erythropoietin treatment

evidence-based research

eye movement, disorders of

eye movement, painful

facial hair, excessive

facial nerve palsy, bilateral

fibrinolytic agents, intra-venous local infusion

gammaglobulin therapy, intravenous

headache, drug induced

headache, recurrent

headache, severe

headache, sudden onset of

headache, throbbing

headache, thunderclap

headache, worst of life

hearing loss

hearing loss, sudden, unilateral

heart wall motion dysfunction

hematoma, intracerebral

heralding manifestation

hypercoagulable state

hypothalamus, damage to

hypothalamus, lesion of

hypothalamus, neoplasm of

hypotonia

hypotonia, infants

iatrogenic neurologic disorders

immunofluorescence

immunosuppressive agents

immunotherapy

impotence

in vitro fertilisation

inappropriate antidiuretic(A.D.H.)hormone

inappropriate antidiuretic(A.D.H.)hormone, CNS involvement with

incidence

infertility

intellectual deterioration

intracerebral hemorrhage

intracerebral hemorrhage, young adult

intracranial hypertension, benign

intracranial pressure, increased

Jakob-Creutzfeldt disease

Jakob-Creutzfeldt disease, variant

jaw pain

Korsakoff's psychosis

labor, complicated

lactic dehydrogenase(LDH)

lateral sinus

lateral sinus thrombosis

leg swelling

lethargy

leukemia, neurologic findings assoc.with

leukocytosis

level of consciousness, decreased

lifestyle

lithium

lumbar puncture, complications of

luteinizing hormone

luteinizing hormone releasing factor

medulla oblongata, lesion of

meningismus

meningoencephalopathy

menopause

mental status, abnormal

metabolic alkalosis

methotrexate

methylhydrazine derivatives

migraine

migraine with aura

mild cognitive impairment

mimics

Mini Mental Status Examination

monoamine oxidase inhibitors

monoclonal antibodies

MRI, CAT scan compared to

MRI, contrast enhanced

MRI, contrast enhanced, cloud-like

MRI, diffusion weighted

multiple sclerosis, risk factors for

muscle pain

muscle weakness

muscle weakness, proximal

myasthenia gravis

myasthenia gravis, drug induced

myasthenia gravis, unmasked

myasthenic syndrome

myelitis

myelitis, longitudinal

myelitis, transverse

myocardial infarction

myoclonus

nausea and vomiting

neck pain

neoplasm, hormone producing, ectopic

neoplasm, pituitary

neoplasm, pituitary, treatment of

neoplasm, primary of CNS

neurologic complications of, surgery

neurologic complications of, systemic cancer

neurologic complications of, systemic disease

neurologic disease

neurologic disease, diagnoses of

neurologic examination, focal

neurologic signs

neurologic symptoms

neuromuscular blockade

neuromuscular disease, electrodiagnosis of

neuromuscular junction, abnormality of

neuromyelitis optica (Devic's disease)

neuromyelitis optica spectrum disorder

neuropathology

neuropathy, peripheral

neurotoxin

night sweats

nitrogen mustard

nonsteroidal anti-inflammatory drug

non-vitamin K antagonist oral anticoagulants

obesity

octreotide

old age, neurology of

optic chiasm

optic chiasm, lesion of

optic nerve, lesion of

optic neuritis

oral contraceptives

oral contraceptives, cerbrovascular disease and

oral contraceptives, neurologic complications with

orthostatic hypotension

osteoporosis

otitis, neurologic complications with

Parkinson disease, incidence

paroxysmal nocturnal hemoglobinuria

penicillamine

periaqueductal lesion

pituitary, enlargement

pituitary, hormones of

platelet inhibiting drugs

pleocytosis of cerebrospinal fluid

posterior leukoencephalopathy syndrome

postpartum

practice guidelines

precipitating factors

precocious puberty

pregnancy, neurologic complications in

premarin

prethrombotic state

prevention of neurologic disorders

primary intracranial hypotension

primary thrombocythemia

protein 14-3-3, cerebrospinal fluid

protein C deficiency

protein S deficiency

psychological testing

remote effect of cancer on the nervous system

reversible cerebral vasoconstrictive syndromes

review article

risk factors

risk-benefit assessment

rituximab

seizure

sensorineural hearing loss

serologic testing

serologic testing, false negative

somatostatin analogue

spinal cord, lesion of

splenic-vein thrombosis

splenomegaly

spongy degeneration of brain

steroid

steroid therapy, CNS treatment and complications with

straight sinus

strokelike episodes

subarachnoid hemorrhage

subarachnoid hemorrhage, cerebral convexity

superior sagittal sinus thrombosis

systemic illness

Takotsubo cardiomyopathy

testosterone, serum, low

tetanus antitoxin

thalamus, infarction of

thalamus, lesion of

thalamus, lesion of-bilateral

tissue plasminogen activator, intravenous

tongue, enlarged

toxins, nervous system

tracheostomy

transdermal medication

transient ischemic attack

trauma

treatment of neurologic disorder

venous thrombosis, non-cerebral

vinblastine

vincristine neurotoxicity

vision, blurred

visual loss

vitamin supplementation

vocal cord paralysis

vomiting, intractable

water channel antibodies

weakness

white matter disease

white matter disease, periventricular

workup

wrist drop

Showing articles 350 to 400 of 3577 << Previous Next >>

An Infant with Episodic Facial Flushing
Neurol 91:278-281, Kang,J.H.,et al, 2018

Bow Hunter Syndrome:A Rare Cause of Posterior Circulation Stroke
Neurol 91:329-331, Jadeja,N. and Nalleballe,K., 2018

Intravenous tPA (Tissue-Type Plasminogen Activator) in Patients with Acute Ischemic Stroke Taking Non-Vitamin K Antagonist Oral Anticoagulants Preceding Stroke
Stroke 49:2237-2240, Jin, C.,et al, 2018

Improved Stroke Prevention in Atrial Fibrillation after the Introduction of Non-Vitamin K Antagonist Oral Anticoagulants
Stroke 49:2122-2128, Forslund, T.,et al, 2018

Valsalva-Triggered Pseudotumor Cerebri Syndrome
Neurol 91:e746-e750, Chan, T.L.H.,et al, 2018

Clnicopathologic Conference Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis
NEJM 379:870-878, CASE 27-2018, 2018

Risk of Ischemic and Hemorrhagic Strokes in Occult and Manifest Cancers
Stroke 49:1585-1592, Andersen, K.K. & Olsen, T.S., 2018

Factor Xa Inhibitors Versus Vitamin K Antagonists for Prevention of Cerebral or Systemic Embolism in Patients with Atrial Fibrillation
Stroke 49:e235-e236, Bruins Slot, K.M.H. & Berge, E., 2018

Interventions for Improving Modifiable Risk Factor Control in the Secondary Prevention of Stroke
Stroke 49:e301-e302, Bridgwood, B.,et al, 2018

Myasthenia Gravis Following Alemtuzumab Therapy for Multiple Sclerosis
Neurol 91:622-624, Midaglia, L.,et al, 2018

Pembrolizumab-Induced Myasthenia Gravis
Neurol 91:e1365-e1367, Algaeed, M.,et al, 2018

Intracerebral Haemorrhage: Current Approaches to Acute Management
Lancet 392:1257-1268, Cordonnier, C.,et al, 2018

Coagulation Test Interpretation in a Patient Taking Direct Oral Anticoagulant Therapy
JAMA 320:1485-1486, Sholzberg, M. & Xu, Y., 2018

Childhood Seizures After Phototherapy
Pediatrics 142:e20180648, Newman, T.B.,et al, 2018

Spinal Brucellosis
NEJM 379:e28, Sacks, C.A., 2018

Use of Newer Disease-Modifying Therapies in Pediatric Multiple Sclerosis in the US
Neurol 91:e1778-e1787, Krysko, K.M.,et al, 2018

Clinicopathologic Conference, Lyme Meningoradiculitis
NEJM 379:1862-1868, Case 34-2018, 2018

Preventive Migraine Drug Approved
JAMA 320:1746, , 2018

Neuroimaging Findings of Zika Virus-Associated Neurologic Complications in Adults
AJNR 39:1967-1974, Hygino da Cruz, L.C.,et al, 2018

Efficacy and Tolerability of Erenumab in Patients with Episodic Migraine in Whom Two-of-Four Previous Preventive Treatments were Unsuccessful: A Randomised, Double-Blind, Placebo-Controlled, Phase 3b Study
Lancet 392:2280-2287,2241, Reuter, U.,et al, 2018

Cranial Dural Arteriovenous Fistula
Stroke 49:332-334, Chen, P.M.,et al, 2018

Mystery Myelitis in Children
JAMA 320:2069, Kuehn, B., 2018

Galcanezumab in Chronic Migraine
Neurol 91:e2211-e2221, Detke, H.C.,et al, 2018

Switching the Manufacturer of Antiepileptic Drugs is Associated with Higher Risk of Seizures: A Nationwide Study of Prescription Data in Germany
Ann Neurol 84:918-925, Lang, J.D.,et al, 2018

Autoimmune Pancerebellitis Associated with Pembrolizumab Therapy
Neurol 91:91-93, Vitt, J.R.,et al, 2018

Drug Reaction with Eosinophilia and Systemic Symptoms after Daclizamub Therapy
Neurol 91:e359-e363, Rauer,S.,et al, 2018

Andexxa-An Antidote for Apixaban and Rivaroxaban
JAMA 320:399-400, , 2018

Clinicopathological Conference, Insulinoma
NEJM 379:376-384, Case 23-2018, 2018

A Headache of a Diagnosis
NEJM 379:475-479, Stern,R.M.,et al, 2018

Postoperative Visual Loss After Anesthesia for Nonocular Surgery
UptoDate May, Lee, L.A. & Newman, N.J., 2018

Adult-Onset Vanishing White Matter Disease
Neurol 90:e1091-e1092, Villar-Quiles, R.N.,et al, 2018

Headache and Altered Mental Status
Neurol 90:e1267-e1270, Spera, K.M.,et al, 2018

Cranial Cavernous Malformations
Stroke 49:1029-1035, Stapleton, C.J. & Barker, F.G., 2018

Cerebral Venous Thrombosis in Older Patients
Stroke 49:197-200, Zuurbier, S.M.,et al, 2018

Acute demyelinating polyneuropathy induced by nivolumab
JNNP 89:435-437, Fukumoto, Y.,et al, 2018

A young woman with symmetric weakness and behavioral disturbance
Neurol 90:e1442-e1447, Rosenberg, J.,et al, 2018

Intracranial Arterial Dolichoectasia and Stenosis
Stroke 49:1135-1140, Zhai, F.,et al, 2018

Long-Term Risk of Hemorrhagic Stroke In Young Patients with Congenital Heart Disease
Stroke 49:1155-1162, Giang, K.W.,et al, 2018

Cerebrovascular Accidents During Mechanical Circulatory Support
Stroke 49:1197-1203, Izzy, S.,et al, 2018

Acute acalculous cholecystitis
Neurol 90:e1548-e1552, Croteau, D.,et al, 2018

Management of Bleeding in Patients Taking Oral Anticoagulants
JAMA 319:2032-2033, Anderson, I.,et al, 2018

Progressive multifocal leukoencephalpathy after fingolimod treatment
Neurol 90:1815-e1821, Berger, J.R.,et al, 2018

A 77-year-old man presenting with episodic expressive aphasia
Neurol 90:e1822-e1826, Shanklin, A.,et al, 2018

Risk of stroke and transient ischaemic attack in patients with a diagnosis of resolved atrial fibrillation: retrospective cohort studies
BMJ 360:k1717, Adderley, N.J.,et al, 2018

Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared with Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation
Stroke 49:1464-1470, Reddy, V.Y.,et al, 2018

Diagnosis and Management of Active Intracranial Atherosclerotic Disease
Stroke 49:e221-e223, Narwal, P.,et al, 2018

Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
NEJM 378:2191-2201, Hart, R.G.,et al, 2018

Mixed-Location Cerebral Hemorrhage/Microbleeds
Neurol 90:e119-e126, Pasi, M.,et al, 2018

Multiple Sclerosis
NEJM 378:169-180, Reich, D.S.,et al, 2018

Practice Guide Update Summary: Mild Cognitive Impairment
Neurol 90:126-135, Petersen, R.C.,et al, 2018

Showing articles 350 to 400 of 3577 << Previous Next >>